Quinine Sulfate

FDA Drug Profile — Quinine Sulfate

Quinine Sulfate is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand name including Quinine Sulfate. Available dosage forms: capsule, powder.

Drug details

Generic Name
Quinine Sulfate
Brand Names
Quinine Sulfate
Application Number
ANDA091661
Sponsor
Teva Pharmaceuticals USA, Inc.
NDC Codes
4
Dosage Forms
CAPSULE, POWDER
Routes
ORAL
Active Ingredients
QUININE SULFATE

Indications and Usage

1 INDICATIONS AND USAGE Quinine sulfate capsule USP is a cinchona alkaloid indicated for treatment of uncomplicated Plasmodium falciparum malaria ( 1 ). Quinine sulfate capsule USP is an antimalarial drug indicated only for treatment of uncomplicated Plasmodium falciparum malaria. Quinine sulfate has been shown to be effective in geographical regions where resistance to chloroquine has been documented [see CLINICAL STUDIES ( 14 )] . Quinine sulfate capsules USP are not approved for: Treatment of severe or complicated P. falciparum malaria. Prevention of malaria. Treatment or prevention of nocturnal leg cramps [see WARNINGS AND PRECAUTIONS ( 5.1 )] .

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.